| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Finasteride | FAERS: 8 | US FAERS | |
| 2 | Octreotide | FAERS: 3 | US FAERS | |
| 3 | Zoledronic Acid | FAERS: 3 | OFFSIDES US FAERS | |
| 4 | Fingolimod Hydrochloride | FAERS: 2 | US FAERS | |
| 5 | Hydroxyurea | FAERS: 2 | US FAERS | |
| 6 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 7 | Isotretinoin | FAERS: 2 | US FAERS | |
| 8 | Tacrolimus | FAERS: 2 | US FAERS | |
| 9 | apixaban | FAERS: 2 | US FAERS | |
| 10 | Dimethyl Fumarate | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Fluticasone | FAERS: 1 | US FAERS | |
| 12 | HhAntag691 | FAERS: 1 | US FAERS | |
| 13 | Insulin Detemir | FAERS: 1 | US FAERS | |
| 14 | Linagliptin | FAERS: 1 | US FAERS | |
| 15 | Norgestrel | FAERS: 1 | US FAERS | |
| 16 | NuvaRing | FAERS: 1 | US FAERS | |
| 17 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 18 | Solifenacin Succinate | FAERS: 1 | US FAERS | |
| 19 | Tadenan | FAERS: 1 | US FAERS | |
| 20 | Vemurafenib | FAERS: 1 | US FAERS | |
| 21 | baricitinib | FAERS: 1 | US FAERS | |
| 22 | dabrafenib | FAERS: 1 | US FAERS | |
| 23 | macitentan | FAERS: 1 | US FAERS | |
| 24 | pazopanib | FAERS: 1 | US FAERS | |
| 25 | Leucovorin | OFFSIDES | ||
| 26 | Lidoderm | OFFSIDES | ||
| 27 | Lorazepam | OFFSIDES | ||
| 28 | Methylprednisolone Acetate | OFFSIDES | ||
| 29 | Nifedipine | Canada Vigilance: 1 | Canada Vigilance | |
| 30 | Octreotide | OFFSIDES | ||
| 31 | Pamidronate | OFFSIDES | ||
| 32 | pimecrolimus | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.